$51.23
6.48% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Target price 2025 - Analyst rating & recommendation

PROCEPT BioRobotics Classifications & Recommendation:

Buy
82%
Hold
18%

PROCEPT BioRobotics Price Target

Target Price $94.67
Price $51.23
Potential
Number of Estimates 9
9 Analysts have issued a price target PROCEPT BioRobotics 2026 . The average PROCEPT BioRobotics target price is $94.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 9 Analysts recommend PROCEPT BioRobotics to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of . Most analysts recommend the PROCEPT BioRobotics stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 224.50 321.96
64.84% 43.41%
EBITDA Margin -40.70% -12.13%
47.39% 70.20%
Net Margin -42.65% -25.32%
52.61% 40.64%

11 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is

$322m
Unlock
. This is
43.41% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$336m 49.65%
Unlock
, the lowest is
$320m 42.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $225m 64.84%
2025
$322m 43.41%
Unlock
2026
$427m 32.67%
Unlock
2027
$543m 27.10%
Unlock
2028
$642m 18.31%
Unlock
2029
$684m 6.45%
Unlock

9 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is

$-39.1m
Unlock
. This is
57.25% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-33.0m 63.89%
Unlock
, the lowest is
$-72.1m 21.08%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-91.4m 13.27%
2025
$-39.1m 57.25%
Unlock
2026
$-1.3m 96.74%
Unlock
2027
$37.2m 3,022.66%
Unlock

EBITDA Margin

2024 -40.70% 47.39%
2025
-12.13% 70.20%
Unlock
2026
-0.30% 97.53%
Unlock
2027
6.85% 2,383.33%
Unlock

5 PROCEPT BioRobotics Analysts have issued a net profit forecast 2025. The average PROCEPT BioRobotics net profit estimate is

$-81.5m
Unlock
. This is
15.34% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-77.2m 19.88%
Unlock
, the lowest is
$-85.9m 10.80%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-95.8m 21.88%
2025
$-81.5m 14.86%
Unlock
2026
$-53.8m 33.96%
Unlock
2027
$-29.3m 45.62%
Unlock
2028
$8.8m 129.92%
Unlock

Net Margin

2024 -42.65% 52.61%
2025
-25.32% 40.64%
Unlock
2026
-12.61% 50.20%
Unlock
2027
-5.39% 57.26%
Unlock
2028
1.36% 125.23%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.75 -1.49
21.88% 14.86%
P/E negative
EV/Sales 7.94

5 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics EPS is

$-1.49
Unlock
. This is
15.34% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.41 19.89%
Unlock
, the lowest is
$-1.57 10.80%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.75 21.88%
2025
$-1.49 14.86%
Unlock
2026
$-0.98 34.23%
Unlock
2027
$-0.54 44.90%
Unlock
2028
$0.16 129.63%
Unlock

P/E ratio

Current -29.13 32.35%
2025
-34.38 18.02%
Unlock
2026
-52.06 51.43%
Unlock
2027
-95.76 83.94%
Unlock
2028
320.19 434.37%
Unlock

Based on analysts' sales estimates for 2025, the PROCEPT BioRobotics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.38 33.80%
2025
7.94 30.27%
Unlock
2026
5.98 24.63%
Unlock
2027
4.71 21.32%
Unlock
2028
3.98 15.48%
Unlock
2029
3.74 6.06%
Unlock

P/S ratio

Current 12.51 32.36%
2025
8.72 30.27%
Unlock
2026
6.57 24.63%
Unlock
2027
5.17 21.32%
Unlock
2028
4.37 15.48%
Unlock
2029
4.11 6.05%
Unlock

Current PROCEPT BioRobotics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Morgan Stanley
Locked
Locked
Locked Feb 26 2025
Truist Securities
Locked
Locked
Locked Feb 26 2025
Wells Fargo
Locked
Locked
Locked Dec 03 2024
Morgan Stanley
Locked
Locked
Locked Dec 02 2024
Jefferies
Locked
Locked
Locked Nov 14 2024
Truist Securities
Locked
Locked
Locked Oct 30 2024
Piper Sandler
Locked
Locked
Locked Oct 08 2024
Analyst Rating Date
Locked
Morgan Stanley:
Locked
Locked
Feb 26 2025
Locked
Truist Securities:
Locked
Locked
Feb 26 2025
Locked
Wells Fargo:
Locked
Locked
Dec 03 2024
Locked
Morgan Stanley:
Locked
Locked
Dec 02 2024
Locked
Jefferies:
Locked
Locked
Nov 14 2024
Locked
Truist Securities:
Locked
Locked
Oct 30 2024
Locked
Piper Sandler:
Locked
Locked
Oct 08 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today